Important Information for Investigators

Which trials need to be registered and how?
What information is kept in the HAREC Registry?
What is happening around the world in regard to trial registration?
 
 

Please note that the International Committee of Medical Journal Editors (ICMJE) requires trials to be registered before their member journals consider submissions for publication.

In relation to this, the WHO International Clinical Trial Registry Platform (ICTRP) is being set up with a view to certify registers in the world around 1Q 2006. ICTRP certified registers will be acceptable to the ICMJE.

ICMJE has recently issued a revised FAQ [cited 13 Feb 2006] indicating its current stances in (i) differentiating its trials registration effort from that of the WHO ICTRP, and (ii) advising investigators to follow its trials registry policy. So far, ICMJE has recognized five Registries and they are accessible at Australia, United States, United Kingdom, Japan, Netherlands. It will also accept registration in any of the primary registries that participate in the WHO International Clinical Trials Portal.

With the launch of WHO Search Portal and Register Network on 4 May 2007. WHO ICTRP advises that investigators should register in only one register that is ICTRP certified, meets ICMJE requirements, and is responsible for obtaining a globally unique identification number (the WHO CT-UID).

Which trials need to be registered and how?

If investigators wish to publish their clinical trial results eventually in ICMJE member journals, they must register the trial at or before the onset of patient enrollment. This applies to any clinical trial starting enrollment after 1 July 2005.

For trials that began enrollment before 1 July 2005, the ICMJE member journals will consider for publication only if the trial is adequately registered before journal submission.

Investigators may wish to register their trials with ClinicalTrials.gov which accepts overseas registrations at no charge.

 
What information is kept in the HAREC Registry?
 
The HAREC Clinical Trial Registry contains the trial information that complies with international standard on trial registration being developed by the WHO International Committee on Trial Registration Platform (ICTRP) and ICMJE. Information kept in the Registry is maintained permanently and is searchable on WHO International Clinical Trials Registry Platform search portal.
 
1. Primary Register and Trial ID#
2. Date of Registration in Primary Register
3. Other Trial ID#s
4. Funding Source(s)
5. Primary Sponsor
6. Secondary Sponsor(s)
7. Contact Person
8. Lead Principal Investigator
9. Public Title
10. Scientifc Title
11. Research Ethics Board Approval
12. Disease or Condition Studied
13. Intervention(s)
14. Inclusion and Exclusion Criteria
15. Study type
16. Date of First Enrollment
17. Target Sample Size
18. Recruitment Status
19. Primary Outcome(s)
20. Secondary Outcomes
 
What is happening around the world in regard to trial registration?
 
The Registry has been monitoring these developments and will continuously follow the standards available.
 
The International Committee of Medical Journal Editors (ICMJE) Statements
 
Investigators who wish to publish in ICMJE journals should observe ICMJE current trials registry policy
1. Is This Clinical Trial Fully Registered? (May 2005)
2. Frequently asked questions: questions about clinical trials registration (February 2006)
 
5 registries have been reviewed and accepted as of January 2006 
ACTR (Australia)
ClinicalTrials.gov (United States)
ISRCTN (United Kingdom)
UMIN-CTR (Japan)
Nederlands Trial Register (Netherlands)
 
The WHO International Clinical Trial Registry Platform
 

The World Health Organization (WHO) is close to arriving at a single worldwide standard on the information that trial investigators must disclose and establishing an International Clinical Trial Registry Platform (ICTRP) Project.

WHO ICTRP has launched Register network in May 2007. The Network composes of Member Registers and Associate Registers. Member Registers will mainly be national or regional registers, and Associate Registers may establish an Associate Membership agreement with a single Member Register to ensure that the trial is affiliated with only one Member Register.

 
International pharmaceutical industry
 
The European Federation of Pharmaceutical Industries and Associations (EFPIA), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the Japanese Pharmaceutical Manufacturers Association (JPMA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) issue a joint statement on the disclosure of clinical trial information via clinical trial registries and databases.
 
United States Food and Drug Administration (FDA)
 
FDA's Guidance for Industry (March 2002) requires new drug application holders to register clinical trials of drug effectiveness for serious or life threatening diseases.
 
EudraCT - European Clinical Trials Database
 
EudraCT is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with EC Directive 2001/20/EC to include all trials for which at least one site falls within the EC's member states. The site is to facilitate submission by investigators, and the database is not yet available to the public.
 
 
HAREC Clinical Trial Registry Administrator
Last Update Date: 13 Oct 2008
Create Date: 31 August 2005